Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”

By Gelao Lucia   Criscitiello Carmen   Esposito Angela   Goldhirsch Aron   Curigliano Giuseppe  

Toxins, Vol. 6, Iss. 3, 2014-03 ,pp. : 914-933

MDPI

Access to resources Recommend Favorite

Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System

By Wefers Christina   Duiveman-de Boer Tjitske   Zusterzeel Petra L. M.   Massuger Leon F. A. G.   Fuchs David   Torensma Ruurd   Wheelock Craig E.   de Vries I. Jolanda M.  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 273-273

MDPI

Access to resources Recommend Favorite

Immune Checkpoints as a Target for Colorectal Cancer Treatment

By Passardi Alessandro   Canale Matteo   Valgiusti Martina   Ulivi Paola  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1324-1324

MDPI

Access to resources Recommend Favorite

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression

By Escalona Ruth M.   Chan Emily   Kannourakis George   Findlay Jock K.   Ahmed Nuzhat  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 450-450

MDPI

Access to resources Recommend Favorite

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment

By Rojas Veronica   Hirshfield Kim M.   Ganesan Shridar   Rodriguez-Rodriguez Lorna  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2113-2113

MDPI

Access to resources Recommend Favorite